Stock Quote TSE Code:4544
Management Policy
Medium-term Management Plan
FY2013 Consolidated Performance Target
(Billion yen)
|
FY2009
|
FY2013
|
CAGR
|
|
|---|---|---|---|
| Net sales |
149.1
|
182.5
|
+5.2%
|
| In Vitro Diagnostics |
32.9
|
39.3
|
+4.5%
|
| Clinical Lab Testing |
91.9
|
113.0
|
+5.3%
|
| Healthcare Related |
24.3
|
30.2
|
+5.6%
|
| Operating income |
19.81
|
26.10
|
+7.1%
|
| Eearnings per share (yen) |
199
|
256
|
- |